Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
4th Antigen Specific Immune Tolerance Digital Summit

4th Antigen Specific Immune Tolerance Digital Summit

Categories

Date of beginning

Wednesday, 27 January 2021

Duration

2 days

City

Online

Contact

Antigen Specific Immune Tolerance Summit Team

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

The 4th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. With momentum building for antigen specific immunotherapies, ASIT 2021 will be the only antigen-specific summit offering thought-leading content to drive the field towards a more precise and ethical antigen-specific approach to drug development. This is the industry's definitive antigen specific drug development forum. Across 3 packed days, thought leaders from Novartis, ImCyse, Harvard Medical School, Toleranzia, Toralgen will reveal insight, data, and lessons learned from the last 12 months to enable you to hurdle the roadblocks preventing the development of clinically safe and effective antigen-specific immunotherapies for autoimmune and immune mediated disorders. https://as-immunetolerance.com/ 26-28 January, 20218am-6pm EST Contact:This email address is being protected from spambots. You need JavaScript enabled to view it. URLs:Brochure: https://go.evvnt.com/695794-0?pid=5569Tickets: https://go.evvnt.com/695794-1?pid=5569 Prices:Drug Developers (Earlybird rates and workshops available): USD 1999.0,Academic (Earlybird rates and workshops available): USD 1799.0,Solution Providers (Earlybird rates and workshops available): USD 2499.0 Speakers: Charlotte Fribert, Chief Executive Officer, Toleranzia AB, Jean Van Rampelbergh, VP Clinical and Regulatory, Imcyse, Jose Carballido, Executive Director (Translational Medicine/ Preclinical Safety), Novartis, Saso Cermerski, VP and Head of Discovery and Translation Immunology, Cue Biopharma, Karsten Sauer, Vice President of Immunology, Repertoire Immune Medicines, Li Zhang, Assistant Professor Medicine-Endocrinology, Baylor College of Medicine, Matthias Von Herrath, Vice President and Senior Medical Officer, Global Chief Medical Officer, Novo Nordisk Date and Time: On Wednesday January 27, 2021 at 8:00 am (ends Thursday January 28, 2021 at 6:00 pm)